REASSESSMENT OF THE EFFECTS OF VASODILATOR DRUGS IN PRIMARY PULMONARY-HYPERTENSION - GUIDELINES FOR DETERMINING A PULMONARY VASODILATOR RESPONSE

被引:96
作者
RICH, S
MARTINEZ, J
LAM, W
LEVY, PS
ROSEN, KM
机构
[1] UNIV ILLINOIS,MED CTR,ABRAHAM LINCOLN SCH MED,COLL MED,DEPT MED,CARDIOL SECT,CHICAGO,IL 60680
[2] UNIV ILLINOIS,SCH PUBL HLTH,PROGRAM EPIDEMIOL & BIOMETRY,CHICAGO,IL 60680
关键词
D O I
10.1016/0002-8703(83)90288-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:119 / 127
页数:9
相关论文
共 22 条
[1]  
BURTON AC, 1972, PHYSL BIOPHYSICS CIR, P90
[2]  
CAMERINI F, 1980, BRIT HEART J, V44, P352
[4]   ROLE OF VASODILATOR THERAPY IN HEART-FAILURE [J].
CHATTERJEE, K ;
PARMLEY, WW .
PROGRESS IN CARDIOVASCULAR DISEASES, 1977, 19 (04) :301-325
[5]   PHARMACOLOGIC BASIS OF ANTIHYPERTENSIVE THERAPY - ROLE OF VASODILATOR DRUGS [J].
CHIDSEY, CA ;
GOTTLIEB, TB .
PROGRESS IN CARDIOVASCULAR DISEASES, 1974, 17 (02) :99-113
[6]   ISOPROTERENOL AS A POTENTIAL PULMONARY VASODILATOR IN PRIMARY PULMONARY-HYPERTENSION [J].
DAOUD, FS ;
REEVES, JT ;
KELLY, DB .
AMERICAN JOURNAL OF CARDIOLOGY, 1978, 42 (05) :817-822
[7]  
ELKAYAM U, 1978, CARDIOVASC MED, V3, P117
[8]   PRIMARY PULMONARY-HYPERTENSION [J].
FISHMAN, AP ;
PIETRA, GG .
ANNUAL REVIEW OF MEDICINE, 1980, 31 :421-431
[9]  
FISHMAN AP, 1963, HDB PHYSL 2, V2, P1167
[10]  
GARDINER J M, 1954, Australas Ann Med, V3, P59